Join to View Full Profile
1959 NE Pacific StSeattle, WA 98195
Phone+1 206-543-2340
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Suman Jayadev, MD is a board certified neurologist in Seattle, Washington. She is currently licensed to practice medicine in Washington and Idaho. She is an Assistant Professor at University of Washington School of Medicine.
Education & Training
University of WashingtonResidency, Neurology, 2001 - 2004- University of WashingtonInternship, Internal Medicine, 2000 - 2001
New York Medical CollegeClass of 2000
Certifications & Licensure
WA State Medical License 2004 - 2026
ID State Medical License 2023 - 2025
American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- Hereditary spastic paraplegia with thin corpus callosum and SPG11 mutation: A neuropathological evaluation.Kathryn P Scherpelz, Rebecca A Yoda, Suman Jayadev, Marie Y Davis, Joshua C Hincks
Neuropathology. 2025-04-01 - 1 citationsMicroglial Responses to Alzheimer's Disease Pathology: Insights From "Omics" Studies.Aquene N Reid, Suman Jayadev, Katherine E Prater
Glia. 2025-03-01 - Unboxing "Omics" in Glial Biology to Understand Neurological Disease.Jonathan R Weinstein, Suman Jayadev, Shane Liddelow, B J L Eggen
Glia. 2025-03-01
Press Mentions
Landmark Population-Based Study Reveals the Prevalence of Vascular and Alzheimer’s Dementias Disease Among American IndiansMay 15th, 2024- New Blood Test Can Detect ‘Toxic’ Protein Years Before Alzheimer’s Symptoms Emerge, Study ShowsDecember 5th, 2022
- ADAD and LOAD: At Cellular Level, They Are Not the SameAugust 20th, 2021
- Join now to see all
Grant Support
- Characterization of AD-related endolysosomal dysfunction in human neural cellsUNIVERSITY OF WASHINGTON2024–2029
- Illuminating early microglial dysfunction in Alzheimer's disease through integration of explainable AI and iPSC modelsUNIVERSITY OF WASHINGTON2024–2026
- Illuminating early microglial dysfunction in Alzheimer's disease through integration of explainable AI and iPSC modelsUNIVERSITY OF WASHINGTON2024–2026
- Illuminating early microglial dysfunction in Alzheimer's disease through integration of explainable AI and iPSC modelsUNIVERSITY OF WASHINGTON2024–2026
- Dissecting the role of sex-linked genes and APOE e4 risk in ADUNIVERSITY OF WASHINGTON2021–2026
- Dissecting the role of sex-linked genes and APOE e4 risk in ADUNIVERSITY OF WASHINGTON2021–2026
- Dissecting the role of sex-linked genes and APOE e4 risk in ADUNIVERSITY OF WASHINGTON2021–2026
- Regulation of diverse microglial phenotypes in neurodegenerationUNIVERSITY OF WASHINGTON2023–2025
- Regulation of diverse microglial phenotypes in neurodegenerationUNIVERSITY OF WASHINGTON2023–2025
